Submissions

Online Submissions

Already have a Username/Password for Molecular and Cellular Biomedical Sciences?
Go to Login

Need a Username/Password?
Go to Registration

Registration and login are required to submit items online and to check the status of current submissions.

 

Author Guidelines

1.    GENERAL TERMS

Molecular and Cellular Biomedical Sciences welcome articles covering all aspects of biomedical sciences. All submitted manuscripts must not be previously published and not under consideration for publication elsewhere. Manuscripts may come from any country but must be written in English. The manuscript may be submitted as a review article, research article, or case report article. There are no submission and processing charges for this journal.

All manuscripts are subjected to peer review. Upon acceptance, authors are allowed to hold the copyright without any restriction. It is the authors' responsibility to obtain permission to reproduce illustrations, tables, etc. from other publication.

 

2.    PREPARATION OF THE MANUSCRIPT

a. Manuscript should be submitted in Word File (.doc).
b. Formatted as standard A4 page setup.
c. The text should be double-spaced with 1-inch margin on the left and right sides.
d. Use 12-point Times New Roman font.
e. Manuscript should be arranged in the following order:
    • Title Page, including title, author (first, middle, last name), author's affiliation, corresponding author's contact information, running title (≤ 8 words),
      keywords (≤ 8 keywords), and any disclaimers
    • Abstract (structure should follow the type of manuscript)
    • Manuscript body (structure should follow the type of manuscript)
    • Acknowledgment, Source of Funding Statement, Conflict of Interest and Author's Contribution
    • Figures and Tables.
f. Number all pages at bottom right.
g. Decimal fraction is written in English version (for thousand use point (,) and decimal use comma (.)).
h. Tables are drawn without vertical lines.
i. Figures should be submitted in jpg, tif, png or gif file format.

 

3.    REQUIREMENTS OF EACH MANUSCRIPT TYPE

  • Review Article: Review Article should consist of no more than 5,000 words, not including the words in abstract, references, table, figure, and figure legend. The manuscript should have no more than 6 figures and/or tables in total and no more than 200 references.
  • Research Article: Research Article should consist of no more than 3,500 words, not including the words in abstract, references, table, figure, and figure legend. The manuscript should have no more than 8 figures and/or tables in total and no more than 40 references.
  • Case Report Article: Case Report Article should consist of no more than 2,500 words, not including the words in abstract, references, table, figure, and figure legend. The manuscript should have no more than 6 figures and/or tables in total and no more than 20 reference.


4. ABSTRACT

Provide an abstract of no more than 300 words (for Review Article) or 250 words (for Research Article and Case Report Article). Structured-abstract should be followed in writing Research Article.


5. REFERENCES

  • References should be according to the Vancouver system.
  • List all authors when there are six or fewer; when there are seven or more, list the first six, followed by "et al.".
  • A sequential number of references in the main text. Please follow in detail all examples below:

Article:
Sandra F, Esposti MD, Ndebele K, Gona P, Knight D, Rosenquist M, et al. Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Alters Mitochondrial Membrane Lipids. Cancer Res. 2005; 65(18): 8286-97.

Book:
Murray PR, Rosenthal KS, Kobayashi GS, Pfaller MA. Medical microbiology. 4th ed. St. Louis: Mosby; 2002.

Chapter in a Book:
Rosenberg GA. Matrix metalloproteinase and proteolytic opening of the blood-brain-barrier in neuroinflammation. In: deVries E, Prat A, editors. The Blood-brain Barrier and Its Microenvironment Basic Physiology To Neurological Disease. New York: Taylor and Francis Group; 2005. p.335-58.

Dissertation/Thesis/Essay:
Arlauckas SP. Near infrared fluorescent choline kinase alpha inhibitors for cancer imaging and therapy [Dissertation]. Philadelphia: University of Pennsylvania; 2015.

Part of Website/Monograph:
Medline Plus [Internet]. Bethesda: US National Library of Medicine; ©2009. Diabetic Kidney Problems [update 2015 Nov 2; cited 2015 Nov 16]. Available from: https://www.nlm.nih.gov/medlineplus/diabetickidneyproblems.html/.

Conference Paper:
Fledelius HS. Myopia and significant visual impairment: global aspects. In: Lin LLK, Shin YF, Hung PT, editors. Myopia Updates II: Proceedings of the 7th International Conference on Myopia 1998 Nov 17-20, Taipei. Tokyo: Springer; 2000. p.3-17.

 

6. UNIT OF MEASUREMENT

  • Authors can express all measurements in Conventional or International System (SI) units.
  • Drug names must use generic names. When proprietary brands are used in research, include the brand name, the name and location (city & country) of the manufacturer in parentheses after the first mention of the generic name.


7. MANUSCRIPT TEMPLATE

You can use templates below for submitting the manuscript to Molecular and Cellular Biomedical Sciences.

 

Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.

  1. The submission has not been previously published, nor is it before another journal for consideration.
  2. Proof of permission was obtained to reproduce illustrations, tables, etc. from other publication.
  3. The submission has been written and structured according to the Author Guidelines.
  4. Author/s has/have to certify that: I have been granted authorization by my co-author/s to enter into these arrangements.
  5. I hereby declare, on behalf of myself and my co-author/s, that:
    • The manuscript submitted is an original work and has neither been published in any other peer-reviewed journal nor is under consideration for publication by any other journal. More so, the work has been carried out in the author/s’ lab and the manuscript does not contravene any existing copyright or any other third party rights.
    • I am/we are the sole author/s of the manuscript and maintain the authority to enter into this agreement and the granting of rights to the publisher (PERI), does not infringe any clause of this agreement.
    • The manuscript contains no such material that may be unlawful, defamatory, or which would, if published, in any way whatsoever, violate the terms and conditions as laid down in the agreement.
    • I/we have taken due care that the scientific knowledge and all other statements contained in the manuscript conform to true facts and authentic formulae and will not if followed precisely, be detrimental to the user.
    • I/we permit the adaptation, preparation of derivative works, oral presentation or distribution, along with the commercial application of the work.
    • No responsibility is assumed by InaBJ and PERI, its staff, or members of the editorial boards for any injury and/or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products instruction, advertisements or ideas contained in a publication by InaBJ.
 

Copyright Notice

Authors are allowed to keep the copyright without any restriction. Submission of a manuscript to the respective journals implies that all author/s have read and agreed to the content of the Covering Letter or the Terms and Conditions. It is a condition of publication that manuscripts submitted to this journal have not been published and will not be simultaneously submitted or published elsewhere. Once submitted to the journal, the author/s will not withdraw their manuscript at any stage prior to publication. 

 

Privacy Statement

The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.